111 (NASDAQ:YI) Earns "Sell (D-)" Rating from Weiss Ratings

111 (NASDAQ:YI - Get Free Report)'s stock had its "sell (d-)" rating reaffirmed by equities researchers at Weiss Ratings in a research note issued on Saturday,Weiss Ratings reports.

111 Trading Down 0.3%

111 stock opened at $7.50 on Friday. 111 has a twelve month low of $4.15 and a twelve month high of $12.60. The stock's fifty day simple moving average is $7.82 and its 200-day simple moving average is $7.52. The firm has a market capitalization of $64.80 million, a P/E ratio of -11.72 and a beta of 0.44.

111 (NASDAQ:YI - Get Free Report) last posted its quarterly earnings data on Thursday, June 19th. The company reported ($0.20) earnings per share for the quarter. The firm had revenue of $486.35 million during the quarter.

Institutional Investors Weigh In On 111

Several hedge funds have recently made changes to their positions in the business. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of 111 during the first quarter worth about $92,000. Deuterium Capital Management LLC purchased a new position in shares of 111 during the 1st quarter worth approximately $81,000. FIL Ltd acquired a new stake in shares of 111 in the 4th quarter valued at approximately $450,000. JPMorgan Chase & Co. lifted its holdings in shares of 111 by 43,619.9% in the 4th quarter. JPMorgan Chase & Co. now owns 306,039 shares of the company's stock valued at $191,000 after buying an additional 305,339 shares during the period. Finally, Napean Trading & Investment Co Singapore PTE Ltd acquired a new position in shares of 111 during the 4th quarter worth $245,000. Institutional investors and hedge funds own 21.32% of the company's stock.

111 Company Profile

111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.